# EMA announces mRNA update to seasonal flu vaccine guidance

The European Medicines Agency says its 2026/2027 recommendations now include mRNA influenza vaccines, alongside an update to its vaccine standardisation annex.

Science · By ITANU Magazine newsroom · Published 2026-11-17T17:12:01.000Z · 1 min read

## Key points

- EMA says it added the mRNA vaccine recommendation on 17 November 2026.
- The agency also reports an update to Annex I on vaccine standardisation reagents.

The European Medicines Agency said it updated its 2026/2027 seasonal influenza vaccine composition recommendations on 17 November 2026 to include mRNA vaccines [1]. The agency also reported changes to Annex I, which covers reagents used in vaccine standardisation [1].

EMA says the recommendations specify which influenza strains or sequences manufacturers should use in vaccines intended to prevent seasonal flu from autumn 2026 [1]. It directs readers to the latest document under its page’s ‘Related documents’ section for the additional strains and sequences [1].

According to the U.S. National Library of Medicine, mRNA stands for messenger RNA; in these vaccines, it provides instructions that cells use to produce a germ’s protein or a fragment of it [3]. The resulting protein prompts an immune response, including antibody production, and cells subsequently break down the mRNA [3].

EMA’s update history lists earlier additions on 7 May 2026 concerning strains for egg-based and live-attenuated influenza vaccines [1]. The agency says a further update on 26 May 2026 covered an A/H3N2 virus suitable for cell-based seasonal vaccines and a B-lineage virus suitable for live-attenuated seasonal vaccines [1].

## Sources

1. [EU recommendations for 2026/2027 seasonal flu vaccine composition](https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition), European Medicines Agency (Primary)
2. [Recommended composition of influenza virus vaccines for use in the 2026-2027 northern hemisphere influenza season](https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2026-2027-northern-hemisphere-influenza-season), World Health Organization (Independent)
3. [What are mRNA vaccines and how do they work?](https://www.medlineplus.gov/genetics/understanding/therapy/mrnavaccines/), U.S. National Library of Medicine (Independent)

ITANU’s newsroom system produced this article with AI and checked it against the sources listed above.

Canonical: https://itanu.org/magazine/ema-announces-mrna-update-flu-vaccine-guidance-xtgoisge/
